[Clinical observations on the use of a new synthetic drug, 1-(p-2-diethylaminoethoxyphenyl)-1-(p-tolyl)-2-(p-chlorophenyl)-ethanol, in the therapy of hypercholesteremic syndromes].
GIOVANNINI
C
C
LINTAS
P L
PL
D001161:Arteriosclerosis / Q000628:therapy*; D000431:Ethanol; D006801:Humans; D011108:Polymers; D013577:Syndrome
D011108:Polymers; D000431:Ethanol; C020845:P-2
ARTERIOSCLEROSIS/therapy